Dr  Magnus Nicolson Mba Frsm Frsc

Dr Magnus Nicolson Mba Frsm Frsc Email and Phone Number

Life Science CEO @ Invizius
Dr Magnus Nicolson Mba Frsm Frsc's Location
Balfron, Scotland, United Kingdom, United Kingdom
Dr Magnus Nicolson Mba Frsm Frsc's Contact Details

Dr Magnus Nicolson Mba Frsm Frsc work email

Dr Magnus Nicolson Mba Frsm Frsc personal email

About Dr Magnus Nicolson Mba Frsm Frsc

I have been Chairman, CEO and Managing Director of public and private life science companies in the US, UK, Sweden, Germany and the Gulf States. My passion is building exceptional teams that efficiently make or deliver life changing products and services. Experience & Skills: Leadership, Project Management, Venture Funding, IPO's, Start Ups & Scale Ups, Partnering & Licensing, cGMP Manufacture, Drug Delivery, API's, Biopharmaceuticals, RNA therapeutics, Cell and Gene Therapies, Exosomes, Immunodiagnostics, Marine Biotechnology, Omega 3's, Chemical & Process Engineering.

Dr Magnus Nicolson Mba Frsm Frsc's Current Company Details
Invizius

Invizius

View
Life Science CEO
Dr Magnus Nicolson Mba Frsm Frsc Work Experience Details
  • Invizius
    Chief Executive Officer
    Invizius May 2024 - Present
    Motherwell, North Lanarkshire, Gb
    Invizius Ltd is developing Second Generation Complement Therapeutics to reduce complement activation during CRRT, Haemodialysis, Peritoneal Dialysis, CPB and other applicable device and therapeutic applications. Complement activation is a driver of renal tubule cell damage, micro and cardiovascular damage as well as a driver of fibrosis and cell transformation. The lead product H-Guard is designed for Acute Haemodialysis applications.
  • Invizius
    Chief Operating Officer: Complement Modulating Therapeutics Preventing Fibrosis And Inflammation.
    Invizius Sep 2019 - Apr 2024
    Motherwell, North Lanarkshire, Gb
  • Scottish Association For Marine Science
    Trustee Sams: Marine Biotechnology/Algae & Crispr
    Scottish Association For Marine Science Jul 2019 - Mar 2024
    Oban, Argyll, Gb
    SAMS are based in the European Marine Science Park at Dunstaffnage on the West Coast of Scotland. SAMS hosts the largest Algal collection in the world and are recognised leaders in global seaweed cultivation. Other projects I am involved in include CRISPR cas enhancement of Omega 3 production in algae and marine worm applications.
  • Ilc Therapeutics Ltd
    Chairman Then Nxd
    Ilc Therapeutics Ltd Jul 2019 - Jan 2022
    Glasgow, Gb
    ILCT uses hybrid interferon alpha to modulate the Innate Immune System in a number of indications: Viral, Oncology, Dermatology and others.
  • Fixed Phage
    Ceo: Bacteriophage Product Development
    Fixed Phage Jan 2018 - Apr 2019
    Fixed Phage spun out of Strathclyde University in 2011 with patents covering the stabilisation of bacteriophages onto a variety of surfaces using corona discharge.
  • Consultant/Independent Contractor
    Owner: International Project Management
    Consultant/Independent Contractor Dec 2015 - Dec 2017
    General & Project Management in Germany and UK, Facility Design, Refinery Design, Omega 3, Continuous Manufacturing, Cell Therapy and ATMP's . Technology areas: cGMP manufacturing, Stem Cells, Immunology Gene Therapy, Oncology and Drug Delivery.
  • Basf Pharma (Callanish) Ltd
    General Manager: Project Management, Process Design And Operations.
    Basf Pharma (Callanish) Ltd Sep 2011 - Nov 2015
    Ludwigshafen, De
    General management responsibility for all activities and staff at the BASF Pharma facility on Lewis as well as for large scale SMB expansion project for API production. Project managed design and build of new Omega 3 manufacturing facility in under 14 months and recruitment of key staff to move company forward at new scale. All regulatory agency audits passed and now providing high quality API lipid products to multiple customers globally.
  • Consultancy
    Independent Business Owner
    Consultancy May 2010 - Sep 2011
    A number of projects in personalised cellular therapy, biobanking, spinal injury and continued consultancy work on the siRNA Ryboquin project I started when CEO of EctoPharma Ltd.
  • Virgin Health Bank
    Chief Operating Officer & Designated Individual (Di)
    Virgin Health Bank May 2009 - May 2010
    Umbilical Cord Banking under Human Tissue Authority License
  • Ectopharma Ltd
    Ceo: Anti-Parasitic And Sirna Development
    Ectopharma Ltd May 2005 - May 2009
    Private Speciality Pharmaceutical and Medical Device Company focusing on parasitology and moving into cancer therapy.
  • Cytokine Pharmasciences
    Vp And Managing Director Uk: Hydrogel Based Drug Delivery In Gynaecology/Obstetrics
    Cytokine Pharmasciences 2002 - 2005
    A drug delivery company based on hydrogel technology and exporting products to over 40 countries sold through distributors like Forest and Ferring. Research focus on obstetrics and autoimmune disease as well as successfully developing biodegradable polymers.
  • Viragen Inc
    Coo And Managing Director: Fundraising/Transgenics/Therapeutic Mabs & Cytokines
    Viragen Inc 1995 - 2002
    AMEX listed Biotechnology company developing biopharmaceutical products in the area of cancer and infectious diseases as well as platform transgenic technology.

Dr Magnus Nicolson Mba Frsm Frsc Skills

Biotechnology Lifesciences Pharmaceutical Industry Biopharmaceuticals Product Development Life Sciences Strategy Commercialization Technology Transfer Management Clinical Development Drug Delivery Leadership Gmp Project Management Infectious Diseases R&d Fda Regulatory Affairs Entrepreneurship Immunology Blood Products Medical Devices Science Drug Discovery Pharmaceutics Biochemistry Clinical Trials Oncology Research And Development Hematology Cancer Neurology Project Planning Validation Drug Development Manufacturing Operations Management Business Development Stem Cells Omega 3 Business Strategy Mergers And Acquisitions Healthcare Management High Performance Liquid Chromatography Cross Functional Team Leadership Negotiation Bacteriophages Genetic Engineering Adcs Start Ups Adult Stem Cells Process Engineering Cell Culture Standard Operating Procedure Start Ups

Dr Magnus Nicolson Mba Frsm Frsc Education Details

  • Strathclyde Business School
    Strathclyde Business School
    Mba
  • University Of Strathclyde
    University Of Strathclyde
    Immunology

Frequently Asked Questions about Dr Magnus Nicolson Mba Frsm Frsc

What company does Dr Magnus Nicolson Mba Frsm Frsc work for?

Dr Magnus Nicolson Mba Frsm Frsc works for Invizius

What is Dr Magnus Nicolson Mba Frsm Frsc's role at the current company?

Dr Magnus Nicolson Mba Frsm Frsc's current role is Life Science CEO.

What is Dr Magnus Nicolson Mba Frsm Frsc's email address?

Dr Magnus Nicolson Mba Frsm Frsc's email address is ma****@****aol.com

What schools did Dr Magnus Nicolson Mba Frsm Frsc attend?

Dr Magnus Nicolson Mba Frsm Frsc attended Strathclyde Business School, University Of Strathclyde.

What are some of Dr Magnus Nicolson Mba Frsm Frsc's interests?

Dr Magnus Nicolson Mba Frsm Frsc has interest in Children, Economic Empowerment, Rugby, Health, Education, Classical And Dark Age History, Poverty Alleviation, Science And Technology, Sailing, Climbing.

What skills is Dr Magnus Nicolson Mba Frsm Frsc known for?

Dr Magnus Nicolson Mba Frsm Frsc has skills like Biotechnology, Lifesciences, Pharmaceutical Industry, Biopharmaceuticals, Product Development, Life Sciences, Strategy, Commercialization, Technology Transfer, Management, Clinical Development, Drug Delivery.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.